BML Investment Partners, L.P. 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:41 pm Purchase | 2024-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP | BML Investment Partners, L.P. | 2,643,907 6.550% | 595,273 (+29.06%) | Filing |
| 2024-09-16 4:42 pm Purchase | 2024-09-10 | 13G | Oramed Pharmaceuticals Inc. ORMP | BML Investment Partners, L.P. | 2,048,634 5.000% | 2,048,634 (New Position) | Filing |